GlobalPharma, a wholly-owned subsidiary of Dubai Investments PJSC, hosted His Excellency Dr Amin Hussain Al Amiri, Assistant Undersecretary for Medical Practice and Licence Sector in the UAE Ministry of Health and his accompanying delegation, Dr Ruqaya Al Bastaki, Director of Drug Department, Ministry of Health and Prevention (MoHAP); and Dr Rita Al Shalouhi, Expert in Pharmaceutical Policies; to the facility located at Dubai Investment Park (DIP).
Abdulaziz Bin Yagub Al Serkal, CEO of Industrial Platform - Dubai Investments PJSC; along with Dr Bassem Albarameh, Acting General Manager of Globalpharma; Dr Idrees Siddiqui, Director of the Globalpharma Site; and Mohamed Alloush, Director of Regulatory Affairs and Registration; welcomed the officials to the Globalpharma facility.
The inspection tour, part of MoHAP’s strategy, aimed at enforcing national standards, strengthening, monitoring, and supervising the function of medical and pharmaceutical institutions, and reinforcing the role of inspection by increasing the number of judicial inspectors throughout the country.
As part of the inspection visit, HE Dr Amin mentioned the company's future plans for the development of the pharmaceutical industry in the country and ways and areas of cooperation with the Ministry of Health to promote and boost desiring success plans in line with UAE Vision 2030.
The flexibility of the MoHAP’s inspection teams dealing with the health amenities and local production facilities, as well as their non-stop communication with them, helps amplify the adherence to laws and enhance the spirit of responsibility and self-censorship among manufacturers and healthcare facilities.
MoHAP pressured on the significance of exports, encouraging local factories to embellish exporting to different countries so that the UAE drug is available throughout all countries of the region, bettering the national economy.